Gold Royalty (GROY) Reports Record Q2 Revenue Up 100% Year-Over-Year

Gold Royalty Corp. (NYSE:GROY) is one of the best Canadian gold stocks to buy according to hedge funds. On July 24, the company announced Q2 2025 earnings, in which it reported record revenue. The total revenue, land agreement proceeds and interest in the quarter increased by approximately 100% year-over-year, reaching $4.4 million. Direct revenues from royalties totaled $3.8 million.

Menna/Shutterstock.com

Also during the quarter, the gold equivalent ounces (GEOs) totaled 1,346 GEOs. For the first six months of 2025, total revenue climbed 25% year-over-year to a record $8.0 million (revenue of $6.9 million), corresponding to 2,595 GEOs.

The company credits the increase in revenue to continued strong commodity prices and production growth from its key royalty interests at several operations, including Canadian Malartic, Borborema, and Borden (Porcupine).

Gold Royalty reaffirmed its full-year 2025 production forecast of 5,700 to 7,000 GEOs. The company noted that production is expected to be concentrated more heavily in the second half of the year as newly started mining operations, including Côté, Vareš, and Borborema, ramp up toward full-scale production.

Gold Royalty Corp. (NYSE:GROY) is a Vancouver-based precious metals-focused royalty company. It provides financing to gold mining firms by acquiring royalties, streams, and similar interests across various stages of mine development. The company’s operations are sustained by gold-linked royalty income, generated from agreements with active and near-production mines throughout North America.

While we acknowledge the potential of GROY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Depressed Stocks to Buy in 2025 and Top 10 Medical AI Companies to Buy According to Analysts.

Disclosure: None. This article is originally published at Insider Monkey.